Effect of dipeptidyl peptidase-4 inhibitor on the progression of coronary artery disease evaluated by computed tomography in patients receiving insulin therapy for type 2 diabetes mellitus.
Young ChoiSeung-Hyun KoKiyuk ChangKi Dong YooSang-Hyun IhmPublished in: Journal of diabetes (2023)
Add-on DPP-4i therapy would be beneficial in preventing coronary artery disease progression in patients with T2DM receiving insulin therapy.
Keyphrases
- glycemic control
- coronary artery
- type diabetes
- computed tomography
- coronary artery disease
- pulmonary artery
- magnetic resonance imaging
- positron emission tomography
- percutaneous coronary intervention
- heart failure
- metabolic syndrome
- cardiovascular disease
- cardiovascular events
- mesenchymal stem cells
- magnetic resonance
- acute coronary syndrome
- cardiovascular risk factors
- contrast enhanced
- skeletal muscle
- pulmonary hypertension
- aortic valve
- dual energy
- pet ct
- ejection fraction
- chemotherapy induced